| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1535-7163.MCT-06-0336 |
| P698 | PubMed publication ID | 17363498 |
| P50 | author | Ronald Pak Cheung Wong | Q79961066 |
| P2093 | author name string | Tim Tak Kwok | |
| Wing Pui Tsang | |||
| Ngai Na Co | |||
| Tsun Yee Tsang | |||
| Pui Yee Chau | |||
| P2860 | cites work | Transactivation of the EGR1 gene contributes to mutant p53 gain of function | Q38334166 |
| P433 | issue | 3 | |
| P304 | page(s) | 1054-1061 | |
| P577 | publication date | 2007-03-01 | |
| P1433 | published in | Molecular Cancer Therapeutics | Q2363144 |
| P1476 | title | p53-R273H gains new function in induction of drug resistance through down-regulation of procaspase-3 | |
| P478 | volume | 6 |
| Q36905671 | Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities |
| Q36910793 | Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing |
| Q38112074 | Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme |
| Q35080476 | Cyclopentenyl cytosine induces senescence in breast cancer cells through the nucleolar stress response and activation of p53. |
| Q28077156 | Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness |
| Q35238838 | Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells |
| Q34305486 | Ginsenoside Rg3 Inhibits Constitutive Activation of NF-κB Signaling in Human Breast Cancer (MDA-MB-231) Cells: ERK and Akt as Potential Upstream Targets |
| Q35755407 | Id3 induces an Elk-1-caspase-8-dependent apoptotic pathway in squamous carcinoma cells |
| Q92890181 | In vitro evaluation of anti-epidermoid cancer activity of Acanthus ebracteatus protein hydrolysate and their effects on apoptosis and cellular proteins |
| Q34978713 | Methoxyacetic acid suppresses prostate cancer cell growth by inducing growth arrest and apoptosis |
| Q37719938 | Molecular mechanisms of chemoresistance in osteosarcoma (Review). |
| Q39393193 | Molecularly targeted therapies for p53-mutant cancers |
| Q39229754 | Mutant TP53 enhances the resistance of glioblastoma cells to temozolomide by up-regulating O(6)-methylguanine DNA-methyltransferase |
| Q33687048 | Mutant p53 gain-of-function in cancer |
| Q38197826 | Mutant p53 in cancer: new functions and therapeutic opportunities |
| Q38846785 | Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation |
| Q92910185 | P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs |
| Q42071893 | PTEN deficiency and mutant p53 confer glucose-addiction to thyroid cancer cells: impact of glucose depletion on cell proliferation, cell survival, autophagy and cell migration. |
| Q30416701 | PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations |
| Q38349935 | Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal |
| Q27006998 | Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53 |
| Q38751430 | Sensitivity to PRIMA-1MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 status |
| Q64974524 | TP53 structural variants in metastatic prostatic carcinoma. |
| Q39005896 | Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53. |
| Q36618628 | Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9 |
| Q37455321 | p53 signaling modulation of cell cycle arrest and viral replication in porcine circovirus type 2 infection cells |
| Q53556002 | p53: a two-faced cancer gene. |
| Q45888635 | p53: balancing tumour suppression and implications for the clinic |
Search more.